Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Cancer Immunol Res. 2017 Jul 3;5(8):685–694. doi: 10.1158/2326-6066.CIR-16-0330

Figure 7. Anti-CTLA-4 and SS1P eradicate injected tumors and uninjected tumors in a bilateral tumor model.

Figure 7

Individual growth curves of 66C14-M tumors implanted in two locations on the mice and treated with PBS (thick arrows) or 25 μg SS1P (thick arrows) alone or in combination with anti-CTLA-4 (thin arrows). The injected tumors are represented in the upper panel and the uninjected tumors are in the lower panel. The number of mice in complete remission and total mice per group are shown in parentheses.